Michael L. Baum
Michael L. Baum is a senior partner of Wisner Baum (formerly Baum Hedlund Aristei & Goldman) based in Los Angeles. For 29 years, Michael was the managing partner of Baum Hedlund until he turned over the reins to R. Brent Wisner at the beginning of 2023.
Under Michael’s stewardship, our firm grew from a small boutique law firm to one of the nation’s leading plaintiffs’ litigation firms that is now known for its cutting edge, superior legal work. While running Baum Hedlund, the firm’s success in challenging cases and precedent-setting legal rulings has helped shape the law for the benefit of those harmed in commercial transportation accidents and by dangerous pharmaceuticals and consumer products. Michael’s ceaseless advocacy in pharmaceutical and consumer fraud litigation has brought our firm international attention and acclaim.
“When I became an attorney in 1985, we were the new kids on the block. We only had dreams of achieving the success we now enjoy,” Michael Baum says. “Our ethos from the beginning was pure and simple: we wanted to use the law to help people who had been wronged and make the world a better place. As much as we have grown over the years, that philosophy has remained, and out of it grew a culture that has attracted talented lawyers like Brent who share the same mission. He is exactly the kind of lawyer and leader that will take this firm to new heights. Wisner Baum is in good hands.”
Our firm has won billions under Michael’s leadership in consumer fraud and product liability cases against some of the world’s largest pharmaceutical and life sciences corporations, including Bayer Corp. (Monsanto), Eli Lilly, Forest Labs, GlaxoSmithKline, and Pfizer, among many others.
As a sophisticated legal team, the firm has helped uncover harmful drug industry practices, chemical manufacturer misconduct and deceptive marketing schemes which have resulted in groundbreaking verdicts, major consumer safety advocacy and improved drug warning labels.
The firm was one of the first law firms in the country to take on Roundup (glyphosate) weed killer cancer cases against Monsanto. Michael and his colleagues served on the trial teams for the first three Roundup trials against Monsanto (Bayer), resulting in $2.424 billion in jury verdicts for the plaintiffs. These trial victories paved the way for settlement resolutions in 2020 worth a combined $10.9 billion, a major milestone for Baum Hedlund and the culmination of more than four years of hard work and perseverance.
During the litigation, his team obtained a trove of internal documents known as the Monsanto Papers, which they ensured were declassified and released to regulatory agencies, scientists, and the general public. With invitations from lawmakers in these countries, Michael traveled with his partner Brent Wisner, to the EU and Canada to brief regulators on the key evidence uncovered in the Monsanto litigation. His influence on public policy concerning Roundup led Politico to choose Michael as one of five "changemakers" in the world making waves in pesticides policy.
Call (855) 948-5098 to Learn About Your Legal Options
Wisner Baum Gardasil Lawyers Position Statement on Proposed HPV Vaccine Requirement in California AB 659Bijan Esfandiari, Gardasil Lawsuit, Michael L. Baum, Pharmaceutical News
Gardasil HPV Vaccine StudiesBijan Esfandiari, Gardasil Lawsuit, Michael L. Baum, Monique Alarcon, Personal Injury, Pharmaceutical News, Stephanie Sherman
Historic Actos RICO Class Action Against Big Pharma Could be Worth BillionsClass Action News, Consumer Lawsuits, Michael L. Baum, Pharmaceutical News, Press Releases, R. Brent Wisner
Exposing HPV Vaccine Dangers During Cervical Cancer Awareness MonthBijan Esfandiari, Gardasil Lawsuit, Michael L. Baum
Baum Hedlund Begins 2023 with a New Name: Wisner BaumAdam M. Foster, Ari S. Friedman, Bijan Esfandiari, Cara J. Luther, Clay Robbins III, Frances M. Phares, Helen E. Tokar, John A. Greaves, Mark H. Schlein, Matthew French, Michael L. Baum, Monique Alarcon, Pedram Esfandiary, Press Releases, R. Brent Wisner, Stephanie Sherman, Timothy A. Loranger, William Crawford Appleby
What Are the Most Common HPV Vaccine Side Effects?Bijan Esfandiari, Gardasil Lawsuit, Michael L. Baum, Stephanie Sherman
Zantac Cancer Lawyers File Lawsuits for Over 7,000 People in All 50 StatesAdam M. Foster, Helen E. Tokar, Michael L. Baum, Pharmaceutical News, R. Brent Wisner, Zantac News
Judicial Panel Consolidates Gardasil Lawsuits in HPV Vaccine MDLBijan Esfandiari, Gardasil Lawsuit, Michael L. Baum, Monique Alarcon, Press Releases